期刊文献+

不同Hoehn-Yahr分期帕金森患者T细胞亚群Th9比例变化及相关性分析 被引量:8

Proportion changes and correlation analysis of Th9 in T cell subsets in patients at different Hoehn-Yahr stages
原文传递
导出
摘要 目的 探讨不同Hoehn-Yahr(H-Y)分期帕金森患者T细胞亚群Th9比例变化及Th9细胞比例与H-Y分期的关系。方法 选取2017年6月-2017年12月嘉兴市第二医院就诊的帕金森患者64例作为观察组,对其进行H-Y分期,另外选取同期健康体检者50例作为对照组,观察2组研究对象Th9细胞比例以及不同H-Y分期患者的Th9细胞比例情况,采用Spearman分析方法对帕金森患者Th9细胞比例与H-Y分期的相关性进行研究。结果 对照组Th9细胞比例为(0. 60±0. 13)%,观察组为(1. 30±0. 37)%,差异有统计学意义(P <0. 01);不同H-Y分期患者的Th9细胞比例比较,均明显高于对照组差异有统计学意义(P <0. 05);Spearman分析显示,帕金森患者Th9细胞比例与H-Y分期呈正相关(r=0. 907,P <0. 05)。结论 帕金森患者Th9细胞比例明显高于健康人群,且随着H-Y分期的升高逐渐增高,可作为病情判断的辅助检测指标。 Objective To explore the proportion of Th9 in T cell subsets of patients with Parkinson's disease at different Hoehn-Yahr(H-Y)stages and the relationship between the proportion of Th9 cells and H—Y stages.Methods A total of 64 F^irkinson's patients treated in the Second Hospital of Jiaxing from Jun.2017 to Dec.2017 were selected as the observation group for H-Y staging.In addition,50 healthy people at the same period were selected as the control group.The proportions of Th9 cells in the two groups were observed and Spearman analysis was used to study the correlation between the proportion of Th9 cells and the H-Y stage in Parkinson's patients.Results The proportion of Th9 cells in the control group was(0.60+0.13)%,that in the observation group was(1.30+0.37)%,and the difference between the two groups was statistically significant(P<0.01).The proportion of Th9 cells in patients with different H-Y stages was statistically significant(P<0.05).Spearman analysis showed that the proportion of Th9 cells in patients with Parkinson's was positively correlated with the H-Y stage(r=0.907,P<0.05).Conclusion The proportion of Th9 cells in patients with Parkinson's disease is significantly higher than that in healthy people,and it increases gradually with the increase of H-Y stage,which can be used as an auxiliary detection indicator for the diagnosis of the disease.
作者 李红胜 宁瑶 李胜兵 陈松劲 衡翔 LI Hong-sheng;NING Yao;LI Sheng-hing;CHEN Song-jin;HENG Xiang(Clinical Laboratory,the Second Hospital of Jiaxing,Jiaxing,Zhejiang 314000,Chirm)
出处 《中国卫生检验杂志》 CAS 2019年第24期2990-2992,共3页 Chinese Journal of Health Laboratory Technology
关键词 Hoehn-Yahr分期 帕金森 T细胞亚群 TH9细胞 相关性 Hoehn-Yahr staging Parkinson's disease T cell subsets Th9 cells Correlation
  • 相关文献

参考文献12

二级参考文献125

  • 1吕荣祥.美多巴联合普拉克索治疗帕金森病的有效性及安全性研究[J].中国生化药物杂志,2014,34(3):153-155. 被引量:46
  • 2张曼,芮宝玲,瞿世和,薛茜,王莅.乌鲁木齐市女性吸毒者艾滋病监测分析[J].中国公共卫生,2005,21(11):1305-1306. 被引量:10
  • 3张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:619
  • 4潘薇,许忠,郑百红.肺炎支原体肺炎患儿急性期外周血IFN-γIL-4的变化[J].中国当代儿科杂志,2006,8(5):373-375. 被引量:21
  • 5中国疾病预防控制中心性病艾滋病预防控制中心.国家免费抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2012:12-19.
  • 6Schapira AH, Olanow CW, Greenamyre JT, et al. Slowing of neuro- degeneration in Parkinson' s disease and Huntington' s disease: future therapeutic erspectives [ J ]. Lancet, 2014,384 ( 9942 ) : 545-555.
  • 7Shin YC, Sheng TI'. The epidemiology of Parkinson' s disease [J]. TzuChiMed ,2010,22(2): 73-81.
  • 8Schapira AH, Olanow CW. Neuroproteetion in Parkinson disease: mysteries, myths, and misconceptions [ J ]. JAMA ,2004 ,291 ( 3 ) : 358-364.
  • 9Schapira AH, Tolosa E. Molecular and clinical prodrome of Par- kinson disease: implications for treatment [J]. Nat Rev Neural, 2010,6(6) : 309-317.
  • 10Blander G, Guarente L. The Sir2 family of protein deacetylases [J]. Annu Rev Biochem 2004,73 : 417-435.

共引文献1605

同被引文献79

引证文献8

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部